Pharmacologic treatment of sleep-disordered breathing

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 3, 1998, Pages 691-699

  Hudgel, David W ^a   Thanakitcharu, Sitthep ^b  

^a METROHEALTH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIHYPERTENSIVE AGENT; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CARBON DIOXIDE; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GABAERGIC RECEPTOR AFFECTING AGENT; GLUTAMATE RECEPTOR AGONIST; HYDRALAZINE; IMIPRAMINE; MEDROXYPROGESTERONE; METOPROLOL; NICOTINE; OPIATE ANTAGONIST; PROTRIPTYLINE; PSYCHOTROPIC AGENT; SABELUZOLE; SEROTONIN AGONIST; THEOPHYLLINE; THEOPHYLLINE DERIVATIVE; THYROID HORMONE; THYROXINE; TRYPTOPHAN;

BREATHING DISORDER; DATA BASE; DRUG MECHANISM; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MALE; MEDICAL LITERATURE; MYXEDEMA; PRIORITY JOURNAL; REVIEW; SLEEP APNEA SYNDROME; TREATMENT INDICATION;

EID: 0031721290     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.3.9802019     Document Type: Review

References (50)

1. Woolf, S. M. 1992. Practice guidelines, a new reality in medicine: II. Methods for developing guidelines. Arch. Intern. Med. 152:946-952.
2. Skatrud, J. B., J. A. Dempsey, and D. J. Kaiser. 1978. Ventilatory response to medroxyprogesterone acetate in normal subjects: time course and mechanism. J. Appl. Physiol. 44:939-944.
3. Zwillich, C. W., M. R. Natalino, F. D. Sutton, and J. V. Weil. 1978. Effects of progesterone on chemosensitivity in normal men. J. Lab. Clin. Med. 92:262-269.
4. Strohl, K. P., N. J. Hensley, N. A. Saunders, S. M. Scharf, R. Brown, and R. H. Ingram. 1981. Progesterone administration and progressive sleep apnea. J.A.M.A. 245:1230-1232.
5. Block, A. J., J. M. Wynne, P. G. Boysen, S. Lindsey, C. Martin, and B. Cantor. 1981. Menopause, medroxyprogesterone and breathing during sleep. Am. J. Med. 70:506-510.
6. Rajagopal, K. R., P. H. Abbrecht, and B. Jabbari. 1986. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest 90:815-821.
7. Cook, W. R., J. J. Benich, and S. A. Wooten. 1989. Indices of severity of obstructive sleep apnea syndrome do not change during medroxyprogesterone acetate therapy. Chest 96:262-266.
8. Kimura, H., D. Tatsumi, F. Kunitomo, S. Okita, H. Tojima, S. Kouchiyama, S. Masuyama, T. Shinozaki, Y. Honda, and T. Kuriyama. 1989. Progesterone therapy for sleep apnea syndrome evaluated by occlusion pressure response to exogenous loading. Am. Rev. Respir. Dis. 139:1198-1206.
9. Cistulli, P. A., D. J. Barnes, R. R. Grunstein, and C. E. Sullivan. 1994. Effect of short term hormone replacement in the treatment of obstructive sleep apnoea in postmenopausal women. Thorax 49:699-702.
10. Collop, N. A. 1994. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Chest 106:792-799.
11. Massumi, R. A., and J. L. Winnacker. 1964. Severe depression of the respiratory center in myxedema. Am. J. Med. 36:876-882.
12. Orr, W. C., J. L. Males, and N. K. Imes. 1981. Myxedema and obstructive sleep apnea. Am. J. Med. 70:1061-1066.
13. Rajagopal, K. R., P. H. Abbrecht, S. S. Derderian, C. Pickett, F. Hofeldt, C. J. Tellis, and C. W. Zwillich. 1984. Obstructive sleep apnea in hypothyroidism. Ann. Intern. Med. 101:491-494.
14. Lin, C., K. Tsan, and P. Chen. 1992. The relationship between sleep apnea syndrome and hypothyroidism. Chest 102:1663-1667.
15. Grunstein, R. R., and C. E. Sullivan. 1988. Sleep apnea and hypothyroidism: mechanisms and management. Am. J. Med. 85:775-779.
16. White, D. P., C. W. Zwillich, C. K. Pickett, N. J. Douglas, L. J. Findley, and J. V. Weil. 1982. Central sleep apnea. Improvement with acetazolamide therapy. Arch. Intern. Med. 142:1816-1819.
17. DeBacker, W. A., J. Verbraecken, M. Willemen, W. Wittesaele, W. DeCook, and P. Van deHeyning. 1995. Central apnea index decreases after prolonged treatment with acetazolamide. Am. J. Respir. Crit. Care Med. 151:87-91.
18. Hackett, P. H., R. C. Roach, G. L. Harrison, R. B. Schoene, and W. J. Mills, Jr. 1987. Respiratory stimulants and sleep periodic breathing at high altitude. Am. Rev. Respir. Dis. 135:896-898.
19. Sharp, J. T., W. S. Druz, V. D'Sousa, and E. Diamond. 1985. Effect of metabolic acidosis upon sleep apnea. Chest 87:619-624.
20. Tojima, H., F. Kunitomo, H. Kimura, K. Tatsumi, T. Kuriyama, and Y. Honda. 1988. Effects of acetazolamide in patients with sleep apnoea syndrome. Thorax 43:113-119.
21. Whyte, K. F., G. A. Gould, M. A. Airlie, C. M. Shapiro, and N. J. Douglas. 1988. Role of protriptyline and acetazolamide in the sleep apnea/ hypopnea syndrome. Sleep 11:463-472.
22. Findley, L. J., M. Boykin, T. Fallon, and J. Belardinelli. 1988. Plasma adenosine and hypoxemia in patients with sleep apnea. J. Appl. Physiol. 64:556-561.
23. Espinoza, H., R. Antic, A. T. Thorton, and R. D. McEvoy. 1987. The effects of aminophylline on sleep and sleep-disordered breathing in patients with obstructive sleep apnea. Am. Rev. Respir. Dis. 136:80-84.
24. Javaheri, S. T., J. Parker, L. Wexler, J. D. Liming, P. Lindower, and G. A. Roselle. 1996. Effect of theophylline on sleep-disordered breathing in heart failure. N. Engl. J. Med. 335:562-567.
25. Guilleminault, C., and B. Hayes, 1983. Naloxone, theophylline, bromocriptine, and obstructive sleep apnea: negative results. Bull. Eur. Physiopathol. Respir. 19:632-634.
26. Mulloy, E., and W. T. McNicholas. 1992. Theophylline in obstructive sleep apnea: a double-blind evaluation. Chest 101:753-757.
27. Gislason, T., M. Almqvist, G. Boman, C.-E. Lindholm, and L. Terenius. 1989. Increased CSF opioid activity in sleep apnea syndrome: regression after successful treatment. Chest 96:250-254.
28. Suratt, P. M., S. C. Wilhoit, E. D. Brown, and L. J. Findley. 1986. Effect of doxapram on obstructive sleep apnea. Bull. Eur. Physiopathol. Respir. 22:127-131.
29. Atkinson, R. L., P. M. Suratt, and L. Recant. 1985. Naloxone improves sleep apnea in obese humans. Int. J. Obes. 9:233-239.
30. Gothe, B., K. P. Strohl, S. Levin, and N. S. Cherniack. 1985. Nicotine: a different approach to treatment of obstructive sleep apnea. Chest 87: 11-17.
31. Davila, D. G., R. D. Hunt, K. P. Offord, C. D. Harris, and J. W. Sherard, Jr. 1994. Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers. Am. J. Respir. Crit. Care Med. 150:469-474.
32. 2 inspired concentrations. Am. Rev. Respir. Dis. 138:16-19.
33. Badr, M.S., J. E. Grossman, and S. A. Weber. 1994. Treatment of refractory sleep apnea with supplemental carbon dioxide. Am. J. Respir. Crit. Care Med. 150:561-564.
34. 2 in a patient with non-obstructive sleep apnoea. Neurology 241:45-48.
35. Gleeson, K., C. W. Zwillich, and D. P. White. 1989. Chemosensitivity and the ventilatory response to airflow obstruction during sleep. J. Appl. Physiol. 67:1630-1637.
36. Clark, R. W., H. S. Schmidt, S. F. Schaal, H. Boudoulas, and D. E. Schuller. 1979. Sleep apnea treatment with protriptyline. Neurology 29:1287-1292.
37. Conway, W. A., F. Zorick, P. Piccione, and T. Roth. 1982. Protriptyline in the treatment of sleep apnoea. Thorax 37:49-53.
38. Brownell, L. G., P. West, P. Sweatman, J. C. Acres, and M. H. Kryger. 1982. Protriptyline in obstructive sleep apnea: a double-blind trial. N. Engl. J. Med. 307:1037-1042.
39. Smith, P. L., E. F. Haponik, R. P. Allen, and E. R. Bleecker. 1983. The effects of protriptyline in sleep-disordered breathing. Am. Rev. Respir. Dis. 127:8-13.
40. Hanzel, D. A., N. G. Proia, and D. W. Hudgel. 1991. Response of obstructive sleep apnea to fluoxetine and protriptyline. Chest 100:416-421.
41. Schmidt, H. S. 1983. L-Tryptophan in the treatment of impaired respiration in sleep. Bull. Eur. Physiopathol. Respir. 19:625-629.
42. Kraiczi, H., P. Dahlof, J. Carlson, H. Ejnell, and J. Hedner. 1997. Paroxetine reduces sleep disordered breathing in obstructive sleep apnea patients (abstract). Am. J. Respir. Crit. Care Med. 155:C47.
43. Mendelson, W. B., M. Maczaj, and J. Holt. 1991: Buspirone administration to sleep apnea patients. J. Clin. Psychopharmacol. 11:71-72.
44. Rubin, A.-H. E., G. G. Alroy, R. Peled, and P. Lavie. 1986. Preliminary clinical experience with imipramine HCl in the treatment of sleep apnea syndrome. Eur. Neurol. 25:81-85.
45. Guilleminault, C., C. Crowe, M. A. Quera-Salva, L. Miles, and M. Partinen. 1988. Periodic leg movement, sleep fragmentation, and central sleep apnoea in two cases: reductions with clonazepam. Eur. Respir. J. 1:762-765.
46. Carley, D. W., S. M. Trbovic, and M. Radulovacki. 1996. Hydralazine reduces elevated sleep apnea index in spontaneously hypertensive (SHR) rats to equivalence with normotensive Wistar-Kyoto rats. Sleep 19:363-366.
47. Weichler, U., B. Herres-Mayer, J. Mayer, K. Weber, R. Hoffmann, and J. H. Peter. 1991. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea activity. Clin. Pharmacol. 78:124-130.
48. Issa, F. G. 1992. Effect of clonidine in obstructive sleep apnea. Am. Rev. Respir. Dis. 145:435-439.
49. Hedner, J., R. Grunstein, B. Ericksson, H. Ejnell. 1996. A double-blind, randomized trial of sabeluzole, a putative glutamate antagonist, in obstructive sleep apnea. Sleep 19:287-289.
50. Finnimore, A. J., M. Froebuck, D. Sajkov, and R. D. McEvoy. 1995. The effects of the GABA agonist, baclofen, on sleep and breathing. Eur. Respir. J. 8:230-234.